Edition:
United States

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

14.90USD
23 May 2018
Change (% chg)

$-0.50 (-3.25%)
Prev Close
$15.40
Open
$15.00
Day's High
$15.45
Day's Low
$14.75
Volume
367,858
Avg. Vol
171,079
52-wk High
$23.20
52-wk Low
$8.07

Select another date:

Tue, May 22 2018

BRIEF-Coherus Prices Public Offering Of Common Stock

* SAYS PUBLIC OFFERING OF 5.17 MILLION COMMON SHARES PRICED AT $14.50PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Coherus Announces Proposed Public Offering Of Common Stock

* COHERUS BIOSCIENCES INC SAYS COMMENCED UNDERWRITTEN PUBLIC OFFERING OF $75,000,000 OF SHARES OF ITS COMMON STOCK Source text for Eikon: Further company coverage:

BRIEF-Coherus Biosciences Q1 Loss Per Share $0.74

* COHERUS BIOSCIENCES REPORTS CORPORATE HIGHLIGHTS AND FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Coherus BioSciences Re-Submits Biologics License Application For CHS-1701

* COHERUS BIOSCIENCES RE-SUBMITS BIOLOGICS LICENSE APPLICATION FOR CHS-1701 (PEGFILGRASTIM BIOSIMILAR CANDIDATE)

BRIEF-Coherus Biosciences Says U.S. Court Grants Motion To Dismiss Patent Infringement Complaint

* COHERUS BIOSCIENCES-U.S. COURT ADOPTED MAGISTRATE JUDGE BURKE'S REPORT & RECOMMENDATION TO GRANT MOTION OF CO TO DISMISS PATENT INFRINGEMENT COMPLAINT

BRIEF-Coherus BioSciences Reports Q4 Loss Per Share $0.84

* COHERUS BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Coherus Biosciences Says ‍Had Cash And Cash Equivalents Of About $126.9 Million

* COHERUS BIOSCIENCES SAYS ‍HAD CASH AND CASH EQUIVALENTS OF ABOUT $126.9 MILLION AS OF DEC 31 - SEC FILING​ Source text : (http://bit.ly/2qqVZLs) Further company coverage:

BRIEF-Coherus Says Judge Issued Under Seal Report & Recommendation In Relation To Patent Infringement Complaint

* COHERUS SAYS U.S. JUDGE RECOMMENDED COURT GRANT CO'S PENDING MOTION TO DISMISS AMGEN'S COMPLAINT FOR FAILURE TO STATE CLAIM

Select another date: